KLA Corp. vs McKesson Corporation — how do they compare? KLA Corp. trades at $204.75 (market cap $261.92B), while McKesson Corporation trades at $898.01 (market cap $105.14B). The key difference: KLA Corp. is far larger — about 2.5× McKesson Corporation's market cap, and KLA Corp. pays the higher dividend (0.46%). Which is the better fit depends on your goals.
| KLAC | MCK | |
|---|---|---|
Market Cap | $261.92B | $105.14B |
Sector | Technology | Health |
52-Week High | $301.71 | $995.69 |
52-Week Low | $84.39 | $659.01 |
Enterprise Value | $263.17B | $111.67B |
Dividend Yield | 0.46% | 0.42% |
Trailing returns across standard periods
Latest headlines on both assets
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →